Sound Medicine – New Disclosure Regulations for Drug and Device Companies

Aaron Carroll

February 13, 2012

Sound Medicine is a radio show produced by the Indiana University School of Medicine and WFYI Public Radio. In the last few years, I’ve become their go-to guy on health policy. So, for those of you who would find your day brightened by the sound of my voice, enjoy the following:

Interview: Aaron Carroll, MD
Director, Center for Health Policy and Professionalism Research
Indiana University School of Medicine

The Food and Drug Administration’s new “sunshine” rule due to take effect soon requires drug and medical device companies to publicly disclose payments they make to physicians who help them develop, assess and promote new products.IU health policy expert Aaron Carroll, MD, discusses the payments and the reasoning behind the new federal standards. Dr. Aaron Carroll directs the Center for Health Policy Research at the IU School of Medicine

The comment period on the disclosure rules ends February 17.

Hidden information below

Aaron Carroll

Aaron E. Carroll, MD, MS is co-Editor-in-Chief of The Incidental Economist and tweets at @aaronecarroll. He is the Chief Health Officer at Indiana University. He is also a Distinguished Professor of Pediatrics and Associate Dean for Research Mentoring at the Indiana University School of Medicine. In addition to contributing regularly to The New York Times and the Atlantic, he is the author of four books, most recently The Bad Food Bible.

Sound Medicine – New Disclosure Regulations for Drug and Device Companies

Hidden information below

Aaron Carroll

The Incidental Economist

Editors In Chief

Managing Editor

Subscribe